EUVIMEDEUVIMED entdecken
Crossref

Cellular and molecular impacts of CELMoDs and IMiD on the induction of myeloid‐derived suppressor cells by myeloma cells

Yui Niiyama-Uchibori iD, Taku Tsukamoto iD, Yu Inoue, Shotaro Chinen iD, Takahisa Nakamura iD, Hiroaki Nagata iD, Haruya Okamoto iD, Takahiro Fujino iD, Shinsuke Mizutani iD, Yuji Shimura iD, Junya Kuroda iD

British Journal of Haematology · 2026-11 · 209 (5) · 2011-2023

DOI: 10.1111/bjh.70787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 24.08.2026. Verfasst von Yui Niiyama-Uchibori und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japa…. Hauptthemen laut MEDLINE: Multiple Myeloma, Myeloid-Derived Suppressor Cells, Thalidomide. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, The Japanese Society of Hematology Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To identify strategies to prevent the induction of monocytic myeloid‐derived suppressor cells (M‐MDSCs) in multiple myeloma (MM), we analysed molecular changes in myeloma and myeloid cells within peripheral blood mononuclear cells (PBMCs) that promote M‐MDSC induction during co‐culture. We then examined the effects of cereblon E3 ligase modulators (CELMoDs), iberdomide (IBER) and mezigdomide (MEZI), compared with pomalidomide (POM), on M‐MDSC induction from PBMCs during co‐culture with human myeloma‐derived cell lines (HMCLs). Co‐culturing PBMCs with HMCLs increased inflammatory, interleukin (IL)‐6‐Janus kinase‐signal transducer and activator of transcription (JAK‐STAT)3 and tumour necrosis factor (TNF)‐α‐associated gene expression in HMCLs, while decreasing interferon‐related genes in myeloid cells. CELMoDs inhibited M‐MDSC induction, with 7.5 nM IBER and 1 nM MEZI as effective as 1 μM POM. In this context, CELMoDs and POM reduced inflammatory genes, including those involved in TNF‐α signalling via nuclear factor‐kappa B (NF‐κB), in HMCLs and lowered pro‐inflammatory genes, including C‐C motif chemokine ligand 5 (CCL5). Conversely, in myeloid cells, CELMoDs and POM enhanced immune‐activating pathways linked to interferon responses. Furthermore, CELMoDs and POM reduced candidate soluble mediators associated with M‐MDSC induction, such as migration‐inhibitory factor (MIF) and IL‐10, in myeloid cells and decreased IL‐10 secretion from IL‐10‐producing HMCLs. In summary, CELMoDs effectively inhibit M‐MDSC induction by altering gene expression in co‐cultured HMCLs and myeloid cells, while also suppressing mediators like IL‐10 and MIF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaMyeloid-Derived Suppressor CellsThalidomideHumansCoculture TechniquesUbiquitin-Protein LigasesCell Line, TumorLeukocytes, MononuclearAdaptor Proteins, Signal Transducing

Stichwörter der Autor:innen

cereblon E3 ligase modulatorsinterleukin‐10macrophage migration‐inhibitory factorsmultiple myelomamyeloid‐derived suppressor cell

Substanzen

ThalidomideUbiquitin-Protein LigasesCRBN protein, humanpomalidomideAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan.
  • Department of Blood Transfusion, Kyoto Prefectural University of Medicine, Kyoto, Japan.

ORCID-Profile: Yui Niiyama-Uchibori, Taku Tsukamoto, Shotaro Chinen, Takahisa Nakamura, Hiroaki Nagata, Haruya Okamoto, Takahiro Fujino, Shinsuke Mizutani, Yuji Shimura, Junya Kuroda

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • The Japanese Society of Hematology Research
  • the Japanese Society for Myeloma Morihiro Research Award

Zitieren

APA

Niiyama-Uchibori, Y., Tsukamoto, T., Inoue, Y., Chinen, S., Nakamura, T., Nagata, H., Okamoto, H., Fujino, T., Mizutani, S., Shimura, Y., & Kuroda, J. (2026). Cellular and molecular impacts of CELMoDs and IMiD on the induction of myeloid‐derived suppressor cells by myeloma cells. British Journal of Haematology, 209(5), 2011-2023. https://doi.org/10.1111/bjh.70787

Vancouver

Niiyama-Uchibori Y, Tsukamoto T, Inoue Y, Chinen S, Nakamura T, Nagata H, et al. Cellular and molecular impacts of CELMoDs and IMiD on the induction of myeloid‐derived suppressor cells by myeloma cells. British Journal of Haematology. 2026;209(5):2011-2023. doi:10.1111/bjh.70787

BibTeX
@article{NiiyamaUchibori2026,
  author = {Niiyama-Uchibori, Yui and Tsukamoto, Taku and Inoue, Yu and Chinen, Shotaro and Nakamura, Takahisa and Nagata, Hiroaki and Okamoto, Haruya and Fujino, Takahiro and Mizutani, Shinsuke and Shimura, Yuji and Kuroda, Junya},
  title = {Cellular and molecular impacts of CELMoDs and IMiD on the induction of myeloid‐derived suppressor cells by myeloma cells},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {209},
  number = {5},
  pages = {2011--2023},
  doi = {10.1111/bjh.70787}
}
Kostenlos starten →